智通财经记者 | 王臻 在加拿大针对中国电动车的关税政策持续调整之际，中国汽车公司在该国市场释放出试水信号。智通财 经注意到，奇瑞正通过系统化招聘，为整车进入加拿大市场推进前期筹备。 上个月，加拿大总理马克·卡尼访华期间宣布，对中国产电动汽车给予每年4.9万辆的配额，配额内适用 6.1%的最惠国关税。有媒体报道称，该配额在未来五年内有望上调。此外，他还表示，超过一半中国 产电动汽车将低于3.5万加元（约18.2万元人民币左右）。 业内人士此前向智通财经表示，加拿大以配额制对中国产电动汽车开放市场，短期内利好特斯拉和吉利 极星品牌。同时，也为中国自主汽车品牌进入该国市场创造条件。 智通财经在招聘网站猎聘平台看到，奇瑞汽车正在招聘面前北美约10个工作岗位，涵盖整车工程、安 全、电子电气架构、智能驾驶以及法规认证等环节。相关岗位普遍要求具备多年专业工作经验，流利英 文能力，以及多元化工作经历。招聘信息显示，产品研发和工程开发仍然以安徽芜湖为核心。 奇瑞在产品与市场岗位上采取了"双地点"配置。产品与市场岗位分别设在芜湖和加拿大多伦多市。智通 财经获悉，加拿大产品与市场岗位应聘人员需三月或者四月到岗。 奇瑞公开招聘产品 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 永義國際集團有限公司 呈交日期: 2026年2月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01218 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.1 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.1 | HKD | | 1,000,000,000 | 本月 ...

( 於百慕達註冊成立之有限公司 ) (股份代號：1218) 提名委員會 職權範圍 2. 成員 3. 權限 EASYKNIT INTERNATIONAL HOLDINGS LIMITED 永義國際集團有限公司 1 1. 目的 1.1 永義國際集團有限公司 (「本公司」) 提名委員會 (「委員會」) 協助 本公司董事(「董事」)會(「董事會」) 進行董事會任命並審查董事 會成員在技術、知識和經驗之平衡，確保董事會成員構成的有序升 級。 2.1 委員會全體成員(「成員」)應當由董事會委任，並應包括至少三名 成員。 2.2 大部分成員應為獨立非執行董事，且委員會須至少包括一名不同 性別的成員。 2.3 委員會主席 (「主席」) 應當由董事會委任，且應當是董事會主席 或獨立非執行董事。 2.4 本公司秘書或其代表應為委員會秘書。 3.1 委員會應就其決策或建議直接向董事會報告。 3.2 委員會獲董事會授權取得獨立專業意見，並且，如有需要可邀請 具備相關經驗及專業知識的外界人士協助。委員會有權批准所有 合理的相關費用及聘用條款，而所有相關費用由本公司承擔。 3.3 委員會有權要求本公司的僱員提供其職責範圍內的資料。 3. ...

Core Insights - The automotive industry is increasingly venturing into humanoid robotics, with companies like Chery, Chang'an, Xiaopeng, and GAC making significant investments in this area since 2025 [2][3] - Chery's approach to robotics focuses on addressing societal pain points and fulfilling specific scene requirements, differentiating it from traditional robotics companies [3][9] Group 1: Company Developments - Chery's humanoid robot, "Wuyou" Intelligent Traffic Police R001, has been deployed for traffic enforcement, showcasing the practical application of robotics in real-world scenarios [5][10] - The company aims to develop a series of robots that serve as work and life assistants, with a focus on various sectors including police collaboration, medical services, and elder care [8][12] Group 2: Market Outlook - Industry experts predict that 2026 will mark the "commercialization year" for the robotics sector, with Chery's subsidiary, Moja Robotics, planning to focus on six core products and establish a domestic channel network [10][11] - A Morgan Stanley report forecasts that the humanoid robotics market could reach $5 trillion by 2050, with a deployment of 1 billion units, indicating a significant growth potential in the industry [11] Group 3: Competitive Landscape - The competition in the humanoid robotics market is just beginning, with many companies still in the early stages of development [11][12] - Chery's existing automotive technology, such as visual perception and battery management, can be leveraged in the robotics sector, providing a competitive edge [12][13] Group 4: Financial Position - Moja Robotics has completed its first round of financing and is not currently facing financial constraints, benefiting from Chery's established global R&D capabilities and supply chain [14][15]

Group 1: 华是科技 - The controlling shareholder of 华是科技 is set to change to 杭州巨准, with a share transfer agreement signed for 12.912 million shares, representing 11.32% of the total share capital [1] - After the transfer, the actual controller will change to 郑剑波, and the existing shareholders will relinquish voting rights on their remaining shares [1] - The company will resume trading on January 20, 2026 [2] Group 2: 盈方微 - 盈方微 plans to acquire 100% of 上海肖克利 and 富士德中国 through a combination of share issuance and cash payment, with the transaction not being contingent on each other [3][4] - The acquisition is expected to meet the criteria for a major asset restructuring as per the regulations [3] - The company will also resume trading on January 20, 2026 [4] Group 3: 江化微 - 江化微's controlling shareholder will change to 上海福迅科技, with a transfer of 9.238 million shares at a price of 20 yuan per share, totaling 1.848 billion yuan, which is 23.96% of the total share capital [5][6] - The company will resume trading on January 20, 2026 [6] Group 4: 沃华医药 - 沃华医药 reported a revenue of 817 million yuan for 2025, a year-on-year increase of 6.96%, and a net profit of 95.7153 million yuan, up 162.93% [7] - The company plans to distribute a cash dividend of 1.46 yuan per 10 shares [7] Group 5: 南网能源 - 南网能源 expects a net profit of 300 million to 360 million yuan for 2025, recovering from a loss of 58.1258 million yuan in the previous year [7] Group 6: 其他公司业绩预告 - Several companies, including 翔鹭钨业, 飞沃科技, and 桂林旅游, have reported significant improvements in their expected net profits for 2025, with increases ranging from 93.75% to over 500% compared to the previous year [8][9][10][11][12][13][14][15]

Group 1 - The company Yongyi International (01218) announced that a special shareholders' meeting will be held on December 15, 2025, to approve the sale agreement and the transactions under it [1] - All conditions precedent under the sale agreement have been fulfilled, and the completion is expected on January 15, 2026 [1] - Upon completion, Zhuoyi will no longer be a wholly-owned subsidiary of the company [1]

Core Viewpoint - Yongyi International (01218) announced that all conditions precedent for the sale and purchase agreement have been fulfilled, with completion expected on January 15, 2026, following shareholder approval at a special meeting on December 15, 2025 [1] Group 1 - The sale and purchase agreement will result in Zhuoyi no longer being an indirect wholly-owned subsidiary of the company after completion [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對 其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部分 內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 董事會欣然宣佈，於股東在2025年12月15日舉行的股東特別大會上批准買賣協 議及其項下擬進行的交易後，所有買賣協議項下的先決條件已獲達成，並於 2026年1月15日完成。 於完成後，卓益將不再為本公司的一間間接全資附屬公司。 誠 如 通 函 內 所 述 的 購 買 價 款 已 獲 支 付 。 截 至 2026 年 1 月 15 日 ， 購 買 價 款 286,800,622港元已通過高山（作為發行人）於2026年1月15日向佳豪（作為票 據持有人）發行的2025年可換股票據支付。根據2025年可換股票據的條款及條 件，合共1,697,045,100股每股面值0.01港元之轉換股份將按初步轉換價每股轉 換股份0.169港元（可予調整）於2025年可換股票據所附的轉換權獲行使後由高 山配發及發行予佳豪。 - 1 - 承董事會命 永義國際集團有限公司 主席兼首席行政總裁 官可欣 EASYKNIT INTER ...

Group 1 - The core point of the article is that Huashi Technology announced a potential change in control due to significant matters being planned by major shareholders, leading to a temporary suspension of its stock trading [1] - Huashi Technology is focused on providing information system integration and technical services for smart city clients, including areas like smart governance, smart living, and smart buildings [1] - The company has experienced a decline in performance since its successful listing on the STAR Market in 2022, with a notable shift from profit to loss in 2025 [2] Group 2 - In the first three quarters of 2025, Huashi Technology reported revenue of 353 million yuan, a year-on-year increase of 60.27%, but a net profit loss of 19.21 million yuan, a significant decline of 310.51% compared to the previous year [2] - The decline in net profit is attributed to lower gross margins and increased bad debt losses [2] - Recently, Huashi Technology invested 22.5 million yuan to acquire a 15% stake in Hangzhou Yuchuang Robot Technology Co., with a pre-investment valuation of 123 million yuan [2] - Following the announcement on January 12, Huashi Technology's stock price surged, reaching a 17.15% increase to close at 29.38 yuan per share, marking a new high in nearly a year, with a market capitalization of 3.351 billion yuan [2]

Focus 1: Rongchang Biologics - Rongchang Biologics signed an exclusive licensing agreement with AbbVie for RC148, potentially receiving up to $4.95 billion in milestone payments [2] - The agreement includes an initial payment of $650 million and tiered royalties based on net sales outside Greater China [2] - This licensing deal is expected to accelerate the global development and commercialization of RC148, enhancing the company's brand value and international influence [2] Focus 2: Jianghuai Microelectronics and Huashi Technology - Jianghuai Microelectronics announced a major matter that may lead to a change in control, resulting in a stock suspension starting January 13, 2026, for up to two trading days [3] - Huashi Technology's major matter also involves potential control changes, with stock suspension effective January 13, 2026, for a similar duration [3] Focus 3: Zhi Te New Materials and *ST Chengchang - Zhi Te New Materials' stock was suspended for review after a 198.57% increase over six consecutive trading days [4] - *ST Chengchang's stock was also suspended due to significant trading anomalies, with four instances of abnormal trading within ten days [4] Earnings Highlights - WuXi AppTec expects a revenue of approximately ¥45.46 billion for 2025, a year-on-year increase of about 15.84%, with a projected net profit of approximately ¥19.15 billion, up 102.65% [6] - Chao Hong Ji anticipates a net profit of ¥436 million to ¥533 million for 2025, representing a growth of 125% to 175% [7] - Asia-Pacific Co. forecasts a net profit of ¥468 million to ¥575 million for 2025, reflecting a growth of 120% to 170% [7] - New Farm Co. expects a net profit of ¥87 million to ¥105 million for 2025, a growth of 50.71% to 81.89% [7] - Cangge Mining anticipates a net profit of ¥3.7 billion to ¥3.95 billion for 2025, a growth of 43.41% to 53.1% [7] - Lianhua Holdings expects a net profit of ¥290 million to ¥330 million for 2025, a growth of 43.15% to 62.90% [8] - Bojun Technology forecasts a net profit of ¥828 million to ¥1.012 billion for 2025, a growth of 35% to 65% [8] - Sanxiang New Materials expects a net profit of approximately ¥100 million to ¥130 million for 2025, a growth of 31.99% to 71.58% [8] Important Matters - Blue Arrow Electronics signed a share acquisition intention agreement to acquire at least 51% of Chengdu Xinyi Technology, with a valuation of up to ¥675 million [12] - The acquisition aims to integrate semiconductor packaging and testing with chip design, enhancing industry synergy [12] - Shanghai Airport received notification of a significant share increase by Taibao Asset, raising its stake to 5% [24] - Kaipu Biotech's actual controller increased shareholding through a block trade, with plans for further purchases [24]